Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
GeneTex G protein-coupled receptor (GPCR) antibodies
GeneTex's goal is to produce the most extensive line of antibodies for human G...
Biosynth Microvesicle Extraction (ME) Kits
By using the highly specific Heat Shock Protein (HSP) binding Vn96 peptide, extracellular...
Bio-Rad Laboratories Annexin V StarBright conjugates
Annexin V StarBright conjugates support detection of early apoptotic cells by flow cytometry,...
